The Week In Cannabis: FDA Sends Warning Letter, DEA Issues Plan For Cultivation, Kevin Durant Joins Board – Yahoo Finance

0

Meanwhile, the U.S. Drug Enforcement Administration issued final details for its plan to allow the cultivation of 3.2 million grams of cannabis for research purposes in 2020, marking a 30% increase from this year. The U.S. Food and Drug Administration sent warning letters to 15 companies for selling products containing CBD in forms the agency said were in legal breach of the Federal Food, Drug, and Cosmetic Act.

Key priorities for the workers include workplace safety, affordable health care, parental leave, and retirement benefits. As a result of a labor peace agreement with UFCW Local 1445, the company remained neutral throughout the union organizing process. The agreement could set a new precedent for relationships between company management and organized labor in the state’s emerging regulated cannabis industry.

https://tinyletter.com/javierhasse” data-reactid=”23″>If you want to get this news recap in your email inbox every week, please subscribe to https://tinyletter.com/javierhasse

Earnings reports were also numerous, with numbers out of the following companies:

Cannabis ETFs delivered big gains. Over the last five trading days:

View more earnings on CGC

More News From The Week

“We are excited to work with DICK’S Sporting Goods and be the first provider of CBD products to the nation’s leading sporting goods retailer,” said Myaderm CEO Eric Smart. “Through this partnership we are able to significantly expand the availability of our therapeutic and industry leading products. This is a great opportunity to launch our revamped CBD Sport Cream line to DICK’S Sporting Goods’ active, loyal customer base nationwide.”

“We are excited to now offer CBD products as part of our sports medicine offering,” said Regan Drew, Senior Buyer, Dick’s Sporting Goods. “We’re constantly evaluating our assortments to ensure we’re providing our customers with access to the latest offerings in the sports medicine world. Recovery is an important part of the athletic experience and a growing industry. As a first-class vendor in this space, Myaderm’s products were a natural fit for us to carry for our customers.” 

Khiron also announced it had received authorization to commercialize psychoactive, high-THC cannabis for both domestic and export purposes, becoming the first and only cannabis company in Colombia to obtain this approval.

“We put a lot of care and dedication into our products at Mary Jane’s Medicinals, so we needed to find a partner with that same level of commitment to excellence. That is why we chose Everest Apothecary. We cannot wait to start serving patients all over the state of New Mexico,” said Dahlia Mertens, Owner of Mary Jane’s Medicinals.

Cresco also disclosed the termination of the equity purchase agreement under which its subsidiary would have obtained the ownership interests of the assets of the medical cannabis dispensary operator VidaCann Ltd. and/or affiliated entities.

“As we look forward to 2020, we are focused on building a nimbler, higher-margin business,” Margot Micallef, Founder and CEO of GABY, told Benzinga. “Over the next three quarters we will optimize our portfolio of 3rd party brands and grow sales of inhouse brands to drive gross margin, intelligently reduce expenses, and continue to opportunistically pursue M&A that compliments GABY’s core strengths and our commitment to shareholders to reach profitability in 2020.”

“Becoming a licensed producer marks an important milestone for True Leaf and supports the development of our growing natural pet care business,” said Darcy Bomford, Founder and CEO of True Leaf. The licensed facility meets EU GMP and HACCP standards required for the ‘cannabis 2.0’ market for edibles, topicals, and capsules in Canada and also opens the door to export cannabis to the European market.”

“We are thrilled to announce the addition of Kiva Confections, California’s leading edible brand. Kiva’s built an industry-leading, premium brand focused on quality and consistency. Their delicious, low-dose options and unique formulations will make excellent additions to Nevada’s growing variety of exceptional cannabis products,” said Kellen O’Keefe, Chief Strategy Officer at Flower One.

The state of Michigan has recalled all marijuana vape cartridges to test for contaminants suspected of contributing to 47 deaths and 2,290 hospitalizations across the U.S. from vaping-related health issues.

Top Stories Of The Week

Check out the top stories on Benzinga Cannabis this week:

  • Analysis Of 195M Instagram Posts Shows Massive Growth Of Interest In CBD, Especially In Beauty Markets
  • Diddy’s Portfolio Manager Launches Her Own Cannabis Company, Calls It ‘Once In A Millennium Opportunity’
  • Meet Cannabiscope: An Easy Tool That Helps You Find The Right Cannabis Products For You
  • How To Become A Cannabis Advocate: NORML And Green Flower Now Offer An Online Course
  • MCBA, Merida Walking The Walk For Social Equity In Cannabis And Hemp
  • Canada’s New Health Minister’s Thoughts On Cannabis: What You Should Know
  • Art And Cannabis Getting Extra: Crumb’s 0,000 Weed Drawing, Keith Haring’s Bongs Line
  • The US Cities Most Interested In Cannabis
  • Exclusive: Canopy Growth’s CEO On The Cannabis Company’s Stock Price, Growth Potential, Global Footprint

Benzinga.com/cannabis” data-reactid=”94″>Check out these and many other cannabis stories on Benzinga.com/cannabis

Events Calendar

0

Benzinga.com. Benzinga does not provide investment advice. All rights reserved.” data-reactid=”106″>© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

This article originally appeared here in https://finance.yahoo.com/news/week-cannabis-fda-sends-warning-151151610.html

Leave a Reply